Allen Investment Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,513
| Closed | -$306K | – | 218 |
|
|
2022
Q4 | $306K | Sell |
1,513
-54
| -3% | -$10.6K | ﹤0.01% | 188 |
|
|
2022
Q3 | $276K | Buy |
1,567
+54
| +4% | +$11.1K | ﹤0.01% | 186 |
|
|
2022
Q2 | $305K | Hold |
1,513
| – | – | ﹤0.01% | 197 |
|
|
2022
Q1 | $343K | Hold |
1,513
| – | – | ﹤0.01% | 201 |
|
|
2021
Q4 | $408K | Hold |
1,513
| – | – | 0.01% | 195 |
|
|
2021
Q3 | $366K | Hold |
1,513
| – | – | 0.01% | 163 |
|
|
2021
Q2 | $359K | Sell |
1,513
-1,342,574
| -100% | -$306M | ﹤0.01% | 157 |
|
|
2021
Q1 | $294M | Sell |
1,344,087
-12,283
| -0.9% | -$2.46M | 4.53% | 10 |
|
|
2020
Q4 | $237M | Sell |
1,356,370
-31,546
| -2% | -$5.45M | 4.03% | 11 |
|
|
2020
Q3 | $224M | Sell |
1,387,916
-47,599
| -3% | -$7.54M | 4.17% | 11 |
|
|
2020
Q2 | $205M | Sell |
1,435,515
-5,275
| -0.4% | -$730K | 4.31% | 7 |
|
|
2020
Q1 | $156M | Buy |
1,440,790
+101,002
| +8% | +$14.6M | 4.69% | 7 |
|
|
2019
Q4 | $195M | Buy |
1,339,788
+54,928
| +4% | +$7.93M | 4.64% | 8 |
|
|
2019
Q3 | $185M | Buy |
1,284,860
+110,647
| +9% | +$16.1M | 4.89% | 6 |
|
|
2019
Q2 | $174M | Buy |
1,174,213
+61,561
| +6% | +$8.59M | 4.98% | 4 |
|
|
2019
Q1 | $146M | Buy |
1,112,652
+127,662
| +13% | +$15.7M | 4.58% | 8 |
|
|
2018
Q4 | $107M | Buy |
984,990
+2,809
| +0.3% | +$376K | 4.31% | 9 |
|
|
2018
Q3 | $147M | Buy |
982,181
+39,928
| +4% | +$6.07M | 5.02% | 5 |
|
|
2018
Q2 | $145M | Buy |
942,253
+20,228
| +2% | +$3.05M | 5.54% | 4 |
|
|
2018
Q1 | $128M | Buy |
922,025
+25,890
| +3% | +$3.8M | 5.34% | 4 |
|
|
2017
Q4 | $123M | Sell |
896,135
-7,129
| -0.8% | -$942K | 5.48% | 5 |
|
|
2017
Q3 | $117M | Buy |
903,264
+50,287
| +6% | +$6.71M | 5.35% | 3 |
|
|
2017
Q2 | $113M | Buy |
852,977
+103,089
| +14% | +$12.6M | 5.42% | 3 |
|
|
2017
Q1 | $92.4M | Buy |
749,888
+111,858
| +18% | +$13.2M | 4.76% | 4 |
|
|
2016
Q4 | $70.4M | Sell |
638,030
-2,604
| -0.4% | -$289K | 4.21% | 6 |
|
|
2016
Q3 | $75.7M | Buy |
640,634
+212,086
| +49% | +$25M | 4.83% | 4 |
|
|
2016
Q2 | $48M | Buy |
428,548
+60,140
| +16% | +$6.47M | 3.33% | 11 |
|
|
2016
Q1 | $37.1M | Buy |
368,408
+64,277
| +21% | +$6.16M | 2.91% | 13 |
|
|
2015
Q4 | $32.3M | Buy |
304,131
+95,995
| +46% | +$9.9M | 2.71% | 14 |
|
|
2015
Q3 | $19.4M | Buy |
208,136
+109,875
| +112% | +$11.4M | 1.86% | 23 |
|
|
2015
Q2 | $10.2M | Buy |
98,261
+21,532
| +28% | +$2.24M | 0.97% | 28 |
|
|
2015
Q1 | $8.31M | Buy |
+76,729
| New | +$7.89M | 0.61% | 45 |
|
Other funds holding LH
Allen Investment Management's LH Position: Q1 2023 in Review
Allen Investment Management sold out of Labcorp (LH) in Q1 2023, closing a stake of 1,513 shares — an estimated $306K sold.
Allen Investment Management first reported a position in LH in Q1 2015 and held it in 32 quarters. The position peaked at $294M in Q1 2021. 941 funds tracked by Wall St. Rank hold LH as of Q1 2023.
- Allen Investment Management reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
- Allen Investment Management sold 1,513 Labcorp shares in Q1 2023, an estimated $306K.
- Allen Investment Management first reported a position in Labcorp in Q1 2015 and held it in 32 quarters.
- Allen Investment Management's Labcorp position peaked at $294M in Q1 2021.
- 941 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.
Based on Allen Investment Management's 13F filing for Q1 2023, filed 9 May 2023.